Baystate Wealth Management LLC Biogen Inc. Transaction History

Baystate Wealth Management LLC

  • $1.36 Billion
  • Q4 2023

A detailed history of Baystate Wealth Management LLC transactions in Biogen Inc. stock. As of the latest transaction made, Baystate Wealth Management LLC holds 964 shares of BIIB stock, worth $145,216. This represents 0.02% of its overall portfolio holdings.

Number of Shares
964
Previous 984 2.03%
Holding current value
$145,216
Previous $252,000 1.19%
% of portfolio
0.02%
Previous 0.02%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 29, 2024
SELL
$222.59 - $267.94 $4,451 - $5,358
-20 Reduced 2.03%
964 $249,000
Q3 2023

Oct 25, 2023
BUY
$253.3 - $285.89 $253 - $285
1 Added 0.1%
984 $252,000
Q2 2023

Sep 21, 2023
BUY
$275.25 - $318.06 $270,570 - $312,652
983 New
983 $280,000
Q4 2022

Jan 12, 2023
SELL
$252.44 - $306.72 $3,534 - $4,294
-14 Reduced 1.4%
983 $272,000
Q3 2022

Nov 10, 2022
BUY
$194.69 - $268.46 $2,725 - $3,758
14 Added 1.42%
997 $266,000
Q1 2022

Apr 19, 2022
SELL
$193.77 - $244.14 $112,580 - $141,845
-581 Reduced 37.15%
983 $207,000
Q2 2021

Jul 26, 2021
SELL
$259.0 - $414.71 $139,083 - $222,699
-537 Reduced 25.56%
1,564 $542,000
Q4 2020

Jan 15, 2021
SELL
$236.26 - $355.63 $90,487 - $136,206
-383 Reduced 15.42%
2,101 $514,000
Q3 2020

Oct 14, 2020
BUY
$264.77 - $305.71 $264 - $305
1 Added 0.04%
2,484 $705,000
Q2 2020

Jul 28, 2020
SELL
$258.66 - $342.55 $29,745 - $39,393
-115 Reduced 4.43%
2,483 $665,000
Q1 2020

Apr 22, 2020
BUY
$268.85 - $341.04 $30,648 - $38,878
114 Added 4.59%
2,598 $822,000
Q4 2019

Jan 21, 2020
SELL
$220.06 - $304.07 $15,184 - $20,980
-69 Reduced 2.7%
2,484 $737,000
Q3 2019

Oct 30, 2019
SELL
$217.44 - $243.88 $4,131 - $4,633
-19 Reduced 0.74%
2,553 $594,000
Q2 2019

Jul 02, 2019
SELL
$219.29 - $241.72 $3,289 - $3,625
-15 Reduced 0.58%
2,572 $606,000
Q1 2019

Apr 25, 2019
BUY
$216.71 - $338.96 $3,250 - $5,084
15 Added 0.58%
2,587 $581,000
Q3 2018

Oct 16, 2018
SELL
$293.51 - $383.83 $293 - $383
-1 Reduced 0.04%
2,572 $868,000
Q2 2018

Jul 17, 2018
BUY
$257.52 - $306.91 $114,081 - $135,961
443 Added 20.8%
2,573 $885,000
Q1 2018

Apr 24, 2018
BUY
$260.13 - $367.91 $160,500 - $227,000
617 Added 40.78%
2,130 $552,000
Q3 2017

Oct 10, 2017
BUY
$281.15 - $329.69 $425,379 - $498,820
1,513
1,513 $498,000

Others Institutions Holding BIIB

# of Institutions
1,038
Shares Held
126M
Call Options Held
1.13M
Put Options Held
1.43M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Baystate Wealth Management LLC Portfolio

Follow Baystate Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baystate Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baystate Wealth Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email